12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Deals

Astellas, Drugs for Neglected Diseases initiative (DNDi) deal

Astellas partnered with DNDi to evaluate the pharma's compounds as potential therapies for leishmaniasis, Chagas disease and human African trypanosomiasis. DNDi will...

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >